Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access February 4, 2014

‘Low — T3 syndrome’ among patients with acute myocardial infarction

Edita Jankauskienė, Jolanta-Justina Vaškelytė and Eglė Rumbinaitė
From the journal Open Medicine

Abstract

[1] Kalofoutis C., Mourouzis I., Galanopoulos G., Dimopoulos A., Perimenis P., Spangu D., et al., Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction, Mol Cell Biochem., 2010, 345, 161–169 http://dx.doi.org/10.1007/s11010-010-0569-410.1007/s11010-010-0569-4Search in Google Scholar

[2] Cohn J.N., Ferrari R., Sharpe N., Cardiac remodeling-concepts and clinical implications: a consensus paper from international forum on cardiac remodeling, J Am Coll Cardiol., 2000, 35, 569–582 http://dx.doi.org/10.1016/S0735-1097(99)00630-010.1016/S0735-1097(99)00630-0Search in Google Scholar

[3] Roberts C.S., Maclean D., Maroko P., Kloner R.A., Early and late remodeling of the left ventricle after acute myocardial infarction, Am J Cardiol., 1984, 54, 3, 407–410 http://dx.doi.org/10.1016/0002-9149(84)90206-610.1016/0002-9149(84)90206-6Search in Google Scholar

[4] Pirolo J.S., Hutchins G.M., Moore G.W., Infarct expansion: pathologic anglysis of 204 patients with a single myocardial infarct, J Am Coll Cardiol., 1986, 7(2), 349–354 http://dx.doi.org/10.1016/S0735-1097(86)80504-610.1016/S0735-1097(86)80504-6Search in Google Scholar

[5] Pfeffer M.A., Braunwald E., Ventricular remodeling after myocardial infarction, Experimental observations and clinical implications, Circ J., 1990, 81(4), 1161–1172 http://dx.doi.org/10.1161/01.CIR.81.4.116110.1161/01.CIR.81.4.1161Search in Google Scholar

[6] Carrabba N., Parodi G., Valenti R., Migliorini A., Bellandi B., Antoniucci D., Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI, Atherosclerosis., 2012, 222, 123–128 http://dx.doi.org/10.1016/j.atherosclerosis.2012.02.02810.1016/j.atherosclerosis.2012.02.028Search in Google Scholar

[7] Mitchell G.F., Lamas G.A., Vaughan D.E., Pfefer M.A., Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape, J Am Coll Cardiol., 1992, 19, 1136–1144 http://dx.doi.org/10.1016/0735-1097(92)90314-D10.1016/0735-1097(92)90314-DSearch in Google Scholar

[8] Rumberger J.A., Behrenbeck T., Breen J.R., Reed J.E., Gersh B.J., Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans, J Am Coll Cardiol., 1993, 21, 673–682 http://dx.doi.org/10.1016/0735-1097(93)90100-F10.1016/0735-1097(93)90100-FSearch in Google Scholar

[9] Springeling T., Kirschbaum S.W., Rossi A., Baks T., Karamermer Y., Schulz C., et al, Late cardiac remodeling after primary percutaneous coronary intervention-five-year cardiac magnetic resonance imaging follow-up, Circ J., 2012, 77(1), 81–88 http://dx.doi.org/10.1253/circj.CJ-12-004310.1253/circj.CJ-12-0043Search in Google Scholar

[10] Galiuto L., Gabrielli F.A., Lanza G.A., Porfidia A., Paraggio L., Barcheta S., et al, Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodelling after acute myocardial infarction,. European Journal of Echocardiography., 2010, 11, 677–682 http://dx.doi.org/10.1093/ejechocard/jeq04110.1093/ejechocard/jeq041Search in Google Scholar PubMed

[11] Galli E., Pingitore A., Iervasi G., The role of thyroid in the pathophysiology of heart failure: clinical evidence, Heart Fail Rev., 2010, 155–169 10.1007/s10741-008-9126-6Search in Google Scholar PubMed

[12] Coceani M., Iervasi G., Pingitore A., Carpeggiani C., L’Abbate A., Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications, Clin Cardiol., 2009, 32(7), 380–385 http://dx.doi.org/10.1002/clc.2057410.1002/clc.20574Search in Google Scholar PubMed PubMed Central

[13] Coceani M., Heart disease in patients with thyroid dysfunction: hyperthyroidism, hypothyroidism and beyonm, Anadolu Kardiyol Derg., 2013, 13(1), 62–6 10.5152/akd.2013.008Search in Google Scholar PubMed

[14] Olivares E.L, Carvalho D.P., Thyroid hormone metabolism in heart failure: iodothyronine deiodinases in focus, Curr Opin Endocrinol Diabetes Obes., 2010, 17, 414–417 http://dx.doi.org/10.1097/MED.0b013e32833d919610.1097/MED.0b013e32833d9196Search in Google Scholar PubMed

[15] De Groot L.J., Non-thyroidal ilness sindrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies, Crit Care Clin., 2006, 22, 57–86 http://dx.doi.org/10.1016/j.ccc.2005.10.00110.1016/j.ccc.2005.10.001Search in Google Scholar PubMed

[16] Bianco A.C, Larsen P.R., Cellular and structural biology of the deiodinases, Thyroid., 2005, 15, 777–786 http://dx.doi.org/10.1089/thy.2005.15.77710.1089/thy.2005.15.777Search in Google Scholar PubMed

[17] Iervasi G., Pingitore A., Landi P., Raciti M., Ripoli A., Scarlattini M., et al., Low-T3 syndrome a strong prognostic predictor of death in patients with heart disease, Circulation., 2003, 107, 708–713 http://dx.doi.org/10.1161/01.CIR.0000048124.64204.3F10.1161/01.CIR.0000048124.64204.3FSearch in Google Scholar PubMed

[18] Gereben B., Zavacki A.M., Ribich S., Kim B.W., Huang S.A., Simonides W.S., et al, Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling, Endocr Rev., 2008, 29, 898–938 http://dx.doi.org/10.1210/er.2008-001910.1210/er.2008-0019Search in Google Scholar PubMed PubMed Central

[19] Simonides W.S., Cardiac thyroid-hormone deiodinative pathways in ventricular hypertrophy and heart failure, In: Iervasi G, Pingitore A. (Eds.), Thyroid and heart failure from pathophysiology to clinics., Springer-Verlag Italia., 2009, 67–77 http://dx.doi.org/10.1007/978-88-470-1143-4_710.1007/978-88-470-1143-4_7Search in Google Scholar

[20] Olivares E.L., Marassi M.P., Fortunato R.S., Da Silva A.C., Costa-e-Sousa R.H., Araujo I.G., et al., Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course stud,. Endocrinology., 2007, 148, 4786–4792 http://dx.doi.org/10.1210/en.2007-004310.1210/en.2007-0043Search in Google Scholar PubMed

[21] Wassen F.W., Schiel A.E., Kuiper G.G., Kaptein E., Bakker O., Visser T.J., et al, Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure, Endocrinology., 2002, 143, 2812–2815 10.1210/endo.143.7.8985Search in Google Scholar PubMed

[22] Pol C., Zuidwijk M., Deel E., Muller A., Visser T.J., Duncker D., et al, Left ventricular myocardial infarction in mice induces sustained cardiac deiodinase type III activity, XXVIII European Section Meeting of the International Society for Heart Research, Medimond International Proceedings, Bologna, Italy., 2008, 57–60 Search in Google Scholar

[23] lymvaios I., Mourouzis I., Cokkinos D.V., Dimopoulos M.A., Toumanidis S.T., Pantos C., Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association, European Journal of Endocrinology., 2011, 165, 1–9 http://dx.doi.org/10.1530/EJE-11-006210.1530/EJE-11-0062Search in Google Scholar PubMed

[24] Cini G., Carpi A., Mechanink J., Cini L., Camici M., Galleta F., et al., Thyroid hormones and the cardiovascular system: pathophysiology and interventions, Biomedicine and Pharmacotherapy., 2009, 63, 742–753 http://dx.doi.org/10.1016/j.biopha.2009.08.00310.1016/j.biopha.2009.08.003Search in Google Scholar PubMed

[25] Pingitore A., Iervasi G., Triiodothyronine (T3) effects on cardiovascular system in patients with heart failure, Recent Patents Cardiovasc Drug Discov., 2008, 3, 19–27 http://dx.doi.org/10.2174/15748900878333162510.2174/157489008783331625Search in Google Scholar PubMed

[26] Friberg L., Werner S., Eggertsen G., Ahnve S., Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002; 162, 1388–1394 http://dx.doi.org/10.1001/archinte.162.12.138810.1001/archinte.162.12.1388Search in Google Scholar PubMed

[27] Ezekowitz J.A., Kaul P., Bakal JA., Armstrong P.W., Welsh R.C., Mcalister F.A., Declining in-hospital mortality and increasing heart failure incidente in elderly patients with first myocardial infarction, J Am Coll Cardiol., 2009, 53, 13–20 http://dx.doi.org/10.1016/j.jacc.2008.08.06710.1016/j.jacc.2008.08.067Search in Google Scholar PubMed

[28] Gajarsa J.J., Kloner R.A., Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities, Heart Fail Rev., 2011, 16, 13–21 http://dx.doi.org/10.1007/s10741-010-9181-710.1007/s10741-010-9181-7Search in Google Scholar PubMed

[29] Pantos C., Mourouzis I., Xinaris C., Papadopoulou-Daifoti Z., Cokkinos D, Thyroid hormone and „cardiac metamorphosis”": potential therapeutic implications, Pharmacology and Therapeutics., 2008, 118, 277–294 http://dx.doi.org/10.1016/j.pharmthera.2008.02.01110.1016/j.pharmthera.2008.02.011Search in Google Scholar PubMed

[30] Pantos C., Mourouzis I., Saranteas T., Clave G., Ligeret H., Noack-Fraissignes P., et al., Thyroid hormone improves postischemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischemia-reperfusion? Basic Research in Cardiology., 2009, 104, 69–77 http://dx.doi.org/10.1007/s00395-008-0758-410.1007/s00395-008-0758-4Search in Google Scholar PubMed

[31] Pantos C., Mourouzis I., Cokkinos DV., New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev., 2011, 16, 79–96 http://dx.doi.org/10.1007/s10741-010-9185-310.1007/s10741-010-9185-3Search in Google Scholar PubMed

[32] Pantos C., Mourouzis I., Xinaris C., Kokkinos A.D., Markais A., Dimopoulos A., et al., Time-dependent changes in the expression of thyroid hormone receptor α1 in the myocardium after acute myocardial infarction: posible implications in cardiac remodeling, Eur J Endocrinol., 2007, 156, 415–424 http://dx.doi.org/10.1530/EJE-06-070710.1530/EJE-06-0707Search in Google Scholar PubMed

[33] Pantos C., Mourouzis I., Cokkinos V., Thyroid hormone and ischemic myocardium, In: Iervasi G, Pingitore A. (Eds.), Thyroid and heart failure from pathophysiology to clinics, Springer-Verlag Italia., 2009, 131–13 http://dx.doi.org/10.1007/978-88-470-1143-4_1310.1007/978-88-470-1143-4_13Search in Google Scholar

Published Online: 2014-2-4
Published in Print: 2014-2-1

© 2013 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow